Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous recombinant human APC for HDM-LPS induced allergic asthma inflammation
NL-OMON35983Active, not recruiting
- Sponsor
- Center for Experimental and Molecular Medicine
- Start
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of drotrecogin alfa in allergic asthma (2 arms), sponsored by Center for Experimental and Molecular Medicine. Started Jul 2011; status: active, not recruiting.
02
Drugs
drotrecogin alfa
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NL-OMON35983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35983.